TickerFacts.

Iqvia Holdings Inc. (IQV): Net Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.36B
Year ended 2025-12-31
$1.39B
Trailing 12 months to 2026-03-31
+7.6%
3-year compound annual growth
+37.3%
5-year compound annual growth
$1.37B2011-12-31: $241.77M2012-12-31: $177.55M2013-12-31: $226.59M2014-12-31: $357.00M2015-12-31: $387.00M2016-12-31: $72.00M2017-12-31: $1.28B2018-12-31: $259.00M2019-12-31: $191.00M2020-12-31: $279.00M2021-12-31: $966.00M2022-12-31: $1.09B2023-12-31: $1.36B2024-12-31: $1.37B2025-12-31: $1.36B$1.36B
2011-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$1.36B-0.9%2026-02-17, From 2025-01-01
2024-12-31$1.37B+1.1%2026-02-17, From 2024-01-01
2023-12-31$1.36B+24.5%2026-02-17, From 2023-01-01
2022-12-31$1.09B+12.9%2025-02-13, From 2022-01-01
2021-12-31$966.00M+246.2%2024-02-15, From 2021-01-01
2020-12-31$279.00M+46.1%2023-02-15, From 2020-01-01
2019-12-31$191.00M-26.3%2022-02-16, From 2019-01-01
2018-12-31$259.00M-79.7%2021-02-12, From 2018-01-01
2017-12-31$1.28Bn/m2020-02-18, From 2017-01-01
2016-12-31$72.00Mn/c2019-02-19, From 2016-01-01
2015-12-31$387.00M+8.4%2018-02-16, From 2015-01-01
2014-12-31$357.00M+57.6%2017-02-16, From 2014-01-01
2013-12-31$226.59M+27.6%2016-02-11, From 2013-01-01
2012-12-31$177.55M-26.6%2015-02-12, From 2012-01-01
2011-12-31$241.77Mn/a2014-02-13, From 2011-01-01

Net Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Iqvia Holdings Inc. (IQV)2025-12-31$1.36B-0.9%
Icon PLC (ICLR)2025-12-31$229.34M-69.0%
Incyte Corp (INCY)2025-12-31$1.29Bn/m
Charles River Laboratories International, Inc. (CRL)2025-12-27-$142.16Mn/m
Medpace Holdings, Inc. (MEDP)2025-12-31$451.12M+11.6%
NRC Health (NRC)2025-12-31$11.60M-53.2%
MaxCyte, Inc. (MXCT)2025-12-31-$44.63Mn/m
OmniAb, Inc. (OABI)2025-12-31-$64.78Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$12.43Mn/m

Compare IQV, ICLR, INCY, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗